Wound-infecting bacteria are typically Pseudomonas
aeruginosa and Staphylococcus epidermidis, both of which form biofilms and become resistant to antibiotics.
To solve this problem, copper nanoparticles (Cu) on graphene oxide
(GO) nanosheets were used as antibacterial materials. Since the excessive
use of antibacterial substances is fatal to normal tissues, GO/Cu
was encapsulated with a gelatin complex to lower the cytotoxicity.
Among the catechol-based substances, gallic acid (GA), which has anti-inflammatory
and antibacterial properties, was used in this study to impart stability
to the gelatin complex. Gelatin (GE) and gallic acid (GA) were combined
by a crosslinking method using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
(EDC)/N-hydroxysuccinimide (NHS) as a crosslinker,
and the crosslinking was confirmed by Fourier transform infrared (FT-IR), 1H NMR, and the fluorescence property of GA. The GO/Cu@GE–GA
microcomplexes exhibited more antibacterial effect against Gram-positive
bacteria (S. epidermidis) and Gram-negative
bacteria (P. aeruginosa) than when
GO/Cu alone was used, and the antibiofilm effect was also confirmed.
The cytotoxicity evaluation for human skin cells (human dermal fibroblast
(HDF)) at the same concentration showed that it had low cytotoxicity
and biocompatibility. This study shows the potential of antimicrobial
gelatin microcomplex in prohibiting infectious bacteria and their
biofilms and controlling the release of antimicrobial substances